https://www.europesays.com/uk/154941/ Gabapentin Market Size to Hit USD 3.55 Billion by 2032, Driven by Rising Cases of Epilepsy, Neuropathic Pain, and Off-Label Use – SNS Insider #Business #ChronicPain #CompoundAnnualGrowthRate #DistributionChannel #Epilepsy #gabapentin #GenericAlternatives #GenericForm #MarketShare #Markets #NeuropathicPain #PostHerpeticNeuralgia #prescription #SegmentAnalysis #SNSInsider #UK #UnitedKingdom